Response to Tanezumab, as assessed by outcome measures in rheumatology-osteoarthritis research society international criteria, in patients with osteoarthritis of the knee or hip
Authors:
- T.J. SchnitzerTST.J. Schnitzer
- A.E. BelloABA.E. Bello
- C.R. WestCWC.R. West
- L. TiveL. Tive
- 1 April 2018
- journal article
- abstracts
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 26, S299